TEVA PHARMACEUTICAL INDUSTRIES LIMITED Payments to Acquire Productive Assets
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Payments to Acquire Productive Assets of $104.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-07-29
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire productive assets for the quarter ending 2026-06-30 was $104.00M, a 8.33% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire productive assets for the quarter ending 2026-03-31 was $168.00M, a 32.28% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire productive assets for the quarter ending 2025-12-31 was $142.00M, a 10.08% increase year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire productive assets for the quarter ending 2025-09-30 was $136.00M, a 8.11% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire productive assets for fiscal 2025 was $501.00M, a 0.60% increase from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire productive assets for fiscal 2024 was $498.00M, a 5.32% decline from fiscal 2023.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire productive assets for fiscal 2023 was $526.00M, a 4.01% decline from fiscal 2022.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED payments to acquire productive assets for fiscal 2022 was $548.00M, a 2.49% decline from fiscal 2021.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $104.00M 10-Q · filed 2026-07-29 | $273.00M 10-Q · filed 2026-07-29 | $414.00M derived: sum of 3 quarters · filed 2026-07-29 | $550.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $168.00M 10-Q · filed 2026-04-29 | $310.00M derived: sum of 2 quarters · filed 2026-04-29 | $446.00M derived: sum of 3 quarters · filed 2026-04-29 | $542.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $142.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $278.00M derived: sum of 2 quarters · filed 2026-02-03 | $374.00M derived: sum of 3 quarters · filed 2026-07-29 | $501.00M 10-K · filed 2026-02-03 |
| 2025-09-30 | $136.00M 10-Q · filed 2025-11-05 | $232.00M derived: sum of 2 quarters · filed 2026-07-29 | $359.00M 10-Q · filed 2025-11-05 | $488.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $96.00M 10-Q · filed 2026-07-29 | $223.00M 10-Q · filed 2026-07-29 | $352.00M derived: sum of 3 quarters · filed 2026-07-29 | $500.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $127.00M 10-Q · filed 2026-04-29 | $256.00M derived: sum of 2 quarters · filed 2026-04-29 | $404.00M derived: sum of 3 quarters · filed 2026-04-29 | $501.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $129.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $277.00M derived: sum of 2 quarters · filed 2026-02-03 | $374.00M derived: sum of 3 quarters · filed 2026-02-03 | $498.00M 10-K · filed 2026-02-03 |
| 2024-09-30 | $148.00M 10-Q · filed 2025-11-05 | $245.00M derived: sum of 2 quarters · filed 2025-11-05 | $369.00M 10-Q · filed 2025-11-05 | $488.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-06-30 | $97.00M 10-Q · filed 2025-07-30 | $221.00M 10-Q · filed 2025-07-30 | $340.00M derived: sum of 3 quarters · filed 2026-02-03 | $489.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-03-31 | $124.00M 10-Q · filed 2025-05-07 | $243.00M derived: sum of 2 quarters · filed 2026-02-03 | $392.00M derived: sum of 3 quarters · filed 2026-02-03 | $511.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2023-12-31 | $119.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $268.00M derived: sum of 2 quarters · filed 2026-02-03 | $387.00M derived: sum of 3 quarters · filed 2026-02-03 | $526.00M 10-K · filed 2026-02-03 |
| 2023-09-30 | $149.00M 10-Q · filed 2024-11-06 | $268.00M derived: sum of 2 quarters · filed 2024-11-06 | $407.00M 10-Q · filed 2024-11-06 | $549.00M derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-06-30 | $119.00M 10-Q · filed 2024-07-31 | $258.00M 10-Q · filed 2024-07-31 | $400.00M derived: sum of 3 quarters · filed 2025-02-05 | $522.00M derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-03-31 | $139.00M 10-Q · filed 2024-05-08 | $281.00M derived: sum of 2 quarters · filed 2025-02-05 | $403.00M derived: sum of 3 quarters · filed 2025-02-05 | |
| 2022-12-31 | $142.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $264.00M derived: sum of 2 quarters · filed 2025-02-05 | $548.00M 10-K · filed 2025-02-05 | |
| 2022-09-30 | $122.00M 10-Q · filed 2023-11-09 | $406.00M 10-Q · filed 2023-11-09 | ||
| 2021-12-31 | $562.00M 10-K · filed 2024-02-12 |